Question explored with the scientific record
Docusate sdodium
Docusate sodium is a stool softener that works poorly as a laxative, and the best head-to-head trial found a cheap fiber beat it.
For chronic constipation, the honest comparison is not docusate versus nothing. It is docusate versus psyllium, a soluble fiber. In a two-week randomized, double-blind trial of 170 adults with chronic constipation, psyllium 5.1 g twice daily beat docusate 100 mg twice daily on nearly every objective measure: stool water content rose 2.33% on psyllium versus 0.01% on docusate [1], bowel movements were 3.5 per week versus 2.9 [1], and total stool output was 359.9 g/week versus 271.9 g/week [1]. The gap widened over the two weeks, with psyllium's stool-water trend 3.34 times steeper [1]. That is a fiber outperforming the drug it is supposed to replace.
| Measure | Psyllium | Docusate |
|---|---|---|
| Stool water change | +2.33% | +0.01% |
| Bowel movements/week | 3.5 | 2.9 |
| Total stool output/week | 359.9 g | 271.9 g |
| Stool water weight/BM | 84.0 g | 71.4 g |
The other two records do not test docusate as a constipation treatment in ordinary people. One is a retrospective database study of critically ill sepsis patients, where docusate tracked with lower 28-day mortality than lactulose [2]; that is a sick, hospitalized population and cannot be stretched to a healthy person with constipation. The other added PEG3350 to routine docusate after pelvic surgery and found no faster first bowel movement [3], meaning docusate itself was never shown to be the active ingredient.
No record here reports docusate's long-term safety, dependence, or electrolyte effects. This retrieval is a sample of one search, not the literature.
My call: for ordinary chronic constipation, try psyllium first; docusate is a weak stool softener with no trial here showing it beats fiber. Confidence: moderate.
Sources used 3
-
Psyllium is superior to docusate sodium for treatment of chronic constipation
In adults with chronic idiopathic constipation, psyllium 5.1 g twice daily increased stool water content and overall objective laxative efficacy compared with docusate sodium 100 mg twice daily in a 2-week randomized, double-blind trial.
DOI: 10.1046/j.1365-2036.1998.00336.x -
Laxative use and 28-day mortality in critically ill sepsis patients: a retrospective cohort study using MIMIC-IV (v3.1)
This study investigates the impact of various laxatives on 28-day mortality and other clinical outcomes in critically ill sepsis patients using the MIMIC-IV database, finding that Docusate Sodium is associated with lower mortality and better recovery compared to Lactulose.
DOI: 10.1186/s40560-025-00797-9 -
Polyethylene Glycol 3350 and Docusate Sodium Compared With Docusate Sodium Alone After Urogynecologic Surgery
In women taking routine docusate sodium after urogynecologic surgery, adding PEG3350 postoperatively did not reduce time to first bowel movement but reduced additional laxative use and improved adherence.
DOI: 10.1097/aog.0000000000001565